Total Debt for Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's latest reported total debt is $12.42B USD. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — combine with cash on hand for net debt, and see total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingTotal DebtSwitch metric
Latest period
$12.42B
YoY change
+11.4%
5Y CAGR
+5.4%
Peak year (2025)
$12.42B
Latest annual
$12.42B
Total Debt history chart for Boston Scientific (BSX) from 1991 to 2025
Total Debt history table for Boston Scientific (BSX) from 1991 to 2025
| Fiscal year | Period ended | Reported | Total Debt | YoY |
|---|---|---|---|---|
| 2025 | $12.42B | +11.4% | ||
| 2024 | $11.15B | +17.4% | ||
| 2023 | $9.49B | +2.3% | ||
| 2022 | $9.28B | -1.8% | ||
| 2021 | $9.45B | -0.9% | ||
| 2020 | $9.54B | -7.2% | ||
| 2019 | $10.28B | +46.2% | ||
| 2018 | $7.03B | +26.0% | ||
| 2017 | $5.58B | +1.7% | ||
| 2016 | $5.48B | -3.4% | ||
| 2015 | $5.68B | +33.2% | ||
| 2014 | $4.26B | +0.5% | ||
| 2013 | $4.24B | -0.4% | ||
| 2012 | $4.26B | -0.1% | ||
| 2011 | $4.26B | -21.6% | ||
| 2010 | $5.44B | -8.1% | ||
| 2009 | $5.92B | -12.3% | ||
| 2008 | $6.75B | -17.6% | ||
| 2007 | $8.19B | -8.0% | ||
| 2006 | $8.90B | +340.7% | ||
| 2005 | $2.02B | -14.7% | ||
| 2004 | $2.37B | +37.2% | ||
| 2003 | $1.73B | +84.5% | ||
| 2002 | $935.00M | -22.3% | ||
| 2001 | $1.20B | +44.4% | ||
| 2000 | $834.00M | -34.7% | ||
| 1999 | $1.28B | -46.6% | ||
| 1998 | $2.39B | +384.6% | ||
| 1997 | $493.50M | +71.5% | ||
| 1996 | $287.80M | +305.4% | ||
| 1995 | $71.00M | +64.7% | ||
| 1994 | $43.10M | +21.4% | ||
| 1993 | $35.50M | +36.0% | ||
| 1992 | $26.10M | +3.6% | ||
| 1991 | $25.20M | — |
Total Debt values are taken from Boston Scientific's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Boston Scientific (BSX) most recent annual total debt stands at $12.42B (2025) – grew 11.4% year-over-year.
Across 2020–2025 (5 years), Boston Scientific total debt produced a CAGR of +5.4% – with the latest reading among the more recent periods of the dataset.
The dataset's maximum total debt sits at $12.42B (2025); the minimum reading of $25.20M dates to 1991.
Boston Scientific (BSX) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $52.57B.
Boston Scientific Total Debt by Year
Boston Scientific Total Debt 2025: $12.42B
Boston Scientific total debt in 2025 was $12.42B, grew 11.4% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Total Debt 2024: $11.15B
Boston Scientific total debt in 2024 was $11.15B, grew 17.4% from 2023.
Boston Scientific Total Debt 2023: $9.49B
Boston Scientific total debt in 2023 was $9.49B, edged up 2.3% from 2022.
Boston Scientific Total Debt 2022: $9.28B
Boston Scientific total debt in 2022 was $9.28B, edged down 1.8% below 2021.
Boston Scientific Total Debt 2021: $9.45B
Boston Scientific total debt in 2021 was $9.45B.
See more financial history for Boston Scientific (BSX).
Sector peers — Total Debt
Companies in the same sector as Boston Scientific, ranked by their latest total debt.
| Company | Total Debt | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $130.96B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $78.39B | Healthcare |
| AbbVie Inc. (ABBV) | $69.07B | Healthcare |
| Amgen Inc. (AMGN) | $54.60B | Healthcare |
| Merck & Co., Inc. (MRK) | $50.53B | Healthcare |
| Johnson & Johnson (JNJ) | $47.93B | Healthcare |
| Eli Lilly and Company (LLY) | $42.50B | Healthcare |
| AstraZeneca PLC (AZN) | $29.70B | Healthcare |
Frequently asked questions
What is Boston Scientific's total debt?
- Latest reported total debt for Boston Scientific (BSX) is $12.42B (period ending December 31, 2025).
How has Boston Scientific total debt changed year-over-year?
- Boston Scientific (BSX) total debt changed +11.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Boston Scientific total debt?
- Boston Scientific (BSX) total debt compound annual growth rate is +5.4% over the most recent 5 years available.
When did Boston Scientific total debt hit its highest annual value?
- Boston Scientific total debt reached its highest annual value of $12.42B in 2025.
What was Boston Scientific total debt in 2024?
- Boston Scientific (BSX) total debt in 2024 was $11.15B.
What was Boston Scientific total debt in 2025?
- Boston Scientific (BSX) total debt in 2025 was $12.42B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BSX Overview
Company profile, financial tools, and key metrics
BSX Revenue Counter
Earns $653.70 every second. See per minute, hour, and day.
BSX Earnings Counter
Earns $112.66 per second net profit. See per minute, hour, and day.
BSX Economic Scale
Exceeds Niger's GDP. Compare with world economies.
BSX What If Invested
What if you had invested $1,000? See historical returns from any date.
BSX How It Makes Money
Discover visual breakdown of $20.61B in revenue — where it comes from and where it goes.
BSX Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BSX Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BSX Daily Price Character
Balanced · 48.8% historical win rate (green days). Streaks & record days.
BSX Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BSX Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.